ResearcherHarvard UniversityActive in the last 2 years
Rushika Miriam Perera
Matched on ORCID iD 0000-0003-2435-2273; OpenAlex author ID A5018139250; NIH RePORTER profile ID 10226096. Sources: funder_awards.
Their work
- Papers
- 13 (first author 1, last author 5)
- Trials
- 0
- Grants
- 6
- Labs led
- 1
- Collaborators
- 51
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 2 grants · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 grant · 2025: 2 papers, 2 grants · 2026: 1 paper, 1 grant
Papers 13
- A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer. Last author DOI 10.1016/j.molcel.2026.05.005↗
- Hypoxia Induces Extensive Protein and Proteolytic Remodeling of the Cell Surface in Pancreatic Adenocarcinoma (PDAC) Cell Lines. Co-author DOI 10.1021/acs.jproteome.4c01037↗
- PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Last author DOI 10.1038/s41586-025-09017-8↗
- Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer. Last author DOI 10.1158/2159-8290.cd-22-0044↗
- Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth. Last author DOI 10.1038/s41556-021-00644-7↗
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Co-author DOI 10.1038/s41586-020-2229-5↗
- Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer. Co-author DOI 10.1080/15548627.2020.1769973↗
- Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. Last author DOI 10.7554/elife.45313↗
- Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Co-author DOI 10.1038/nature14587↗
- Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up. Co-author DOI 10.1158/2159-8290.cd-15-0671↗
- Stromal response to Hedgehog signaling restrains pancreatic cancer progression. First author DOI 10.1073/pnas.1411679111↗
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Co-author DOI 10.1038/nature12040↗
- Ready, set, go: the EGF receptor at the pancreatic cancer starting line. Co-author DOI 10.1016/j.ccr.2012.08.019↗
Grants 6
- Identifying and disabling new pathways for macromolecular recycling in pancreatic cancer R01CA301386↗
- Targeting the autophagy-lysosome system to block pancreatic cancer R01CA251726↗
- Dissecting new mechanisms of lysosome quality control in health and disease R01CA260249↗
- Identifying Molecular Drivers of Cellular Plasticity in Pancreatic Cancer R01CA240603↗
- Targeting Nutrient Scavenging Pathways That Fuel Pancreatic Cancer Growth AWARD pancan:2016-rushika-perera-phd-targeting-nutrient-scavenging-pathways-t
- Tracking tumor evolution through in vivo organelle profiling DP2CA216364↗
Closest collaborators
The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roberto Zoncu · 3 shared papers, 1 shared grant, 2015–2026 · strength 1.60
- Grant Identifying and disabling new pathways for macromolecular recycling in pancreatic cancer R01CA301386↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth. DOI 10.1038/s41556-021-00644-7↗
- Gilles Rademaker · 4 shared papers, 2021–2026 · strength 0.67
- Paper A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer. DOI 10.1016/j.molcel.2026.05.005↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in … DOI 10.1158/2159-8290.cd-22-0044↗
- Anthony C. Venida · 4 shared papers, 2020–2026 · strength 0.62
- Paper A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer. DOI 10.1016/j.molcel.2026.05.005↗
- Paper Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer. DOI 10.1080/15548627.2020.1769973↗
- Paper Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in … DOI 10.1158/2159-8290.cd-22-0044↗
- Grace Kim · 3 shared papers, 2020–2025 · strength 0.38
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth. DOI 10.1038/s41556-021-00644-7↗
- Paper Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. DOI 10.1038/s41586-020-2229-5↗
- Nabeel M. Bardeesy · 6 shared papers, 2012–2019 · strength 0.37
- Paper Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up. DOI 10.1158/2159-8290.cd-15-0671↗
- Paper Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. DOI 10.7554/elife.45313↗
- Paper Ready, set, go: the EGF receptor at the pancreatic cancer starting line. DOI 10.1016/j.ccr.2012.08.019↗
- Irene Lui · 1 shared paper, 2025 · strength 0.28
- Lisa Kirkemo · 1 shared paper, 2025 · strength 0.28
- James A Wells · 1 shared paper, 2025 · strength 0.28
- Alec C. Kimmelman · 3 shared papers, 2013–2020 · strength 0.28
- Paper Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer. DOI 10.1080/15548627.2020.1769973↗
- Paper Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. DOI 10.1038/s41586-020-2229-5↗
- Paper Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. DOI 10.1038/nature12040↗
- Marine Berquez · 1 shared paper, 2026 · strength 0.26
- Keisuke Yamamoto · 2 shared papers, 2020 · strength 0.25
- Joseph Douglas Mancias · 2 shared papers, 2020–2022 · strength 0.21
- Suprit Gupta · 2 shared papers, 2020–2021 · strength 0.20
- Michael Guenther · 1 shared paper, 2025 · strength 0.18
- Michael Haas · 1 shared paper, 2025 · strength 0.18
- Steffen Ormanns · 1 shared paper, 2025 · strength 0.18
- Stephan Krüger · 1 shared paper, 2025 · strength 0.18
- Lisa Miller‐Phillips · 1 shared paper, 2025 · strength 0.18
- Volker Heinemann · 1 shared paper, 2025 · strength 0.18
- Eric Andrew Collisson · 1 shared paper, 2025 · strength 0.18
- Jen Jen Yeh · 1 shared paper, 2025 · strength 0.18
- Stefan Hubert Boeck · 1 shared paper, 2025 · strength 0.18
- Gina M. DeNicola · 1 shared paper, 2022 · strength 0.12
- Mirunalini Ravichandran · 1 shared paper, 2022 · strength 0.12
- Annan Yang · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.